Inventor · disambiguated record
Thomas Matthew Baker
Also filed as: BAKER THOMAS · BAKER THOMAS MATTHEW
11 granted patents·6 pending applications·52 citations·filing 2014–2025
88Inventor score
Files withRESPIVERT LTD4KALVISTA PHARMACEUTICALS LTD3NIMBUS CLIO INC3COMPASS PATHFINDER LTD2CORCEPT THERAPEUTICS INC2
Top patents by PatentIndex Score
17 records- 0193US9481648B2Kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Nov 1, 2016·22 cites·24 claims
- 0290US10125100B2Kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Nov 13, 2018·6 cites·4 claims
- 0389US9751837B2Kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Sep 5, 2017·6 cites·25 claims
- 0483US11542238B2Pyrimidine cyclohexenyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jan 3, 2023·5 cites·32 claims
- 0583US9890185B2Urea derivatives useful as kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Feb 13, 2018·8 cites·18 claims
- 0682US10435361B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2017·Granted Oct 8, 2019·3 cites·22 claims
- 0782US10392346B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2018·Granted Aug 27, 2019·2 cites·6 claims
- 0870US12018001B2Pyrimidine cyclohexenyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·14 claims
- 0969US10941115B2Kinase inhibitorsOXULAR ACQUISITIONS LTD·Filed 2019·Granted Mar 9, 2021·0 cites·17 claims
- 1069US2023250080A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1167US2025066394A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 1266US2025066300A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl OLIGOMERIC DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 1364US11613527B2Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Granted Mar 28, 2023·0 cites·46 claims
- 1462US2025263399A1Cbl-b modulators and uses thereofNIMBUS CLIO INC·Filed 2025·Application pending·0 cites
- 1560US12325697B2CBL-B modulators and uses thereofNIMBUS CLIO INC·Filed 2022·Granted Jun 10, 2025·0 cites·8 claims
- 1648US2022289727A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1747US2025163038A1Cbl-b modulators and uses thereofNIMBUS CLIO INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Matthew Baker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →